7th annual World Vaccine Congress Asia 2013 (June 17-20, Singapore)

The 7^th annual World Vaccine Congress Asia 2013 will take place next June 17-20 at Grand Copthorne Waterfront Hotel, Singapore and is the most strategic event in Asia that brings together more than 300 leading vaccine stakeholders and decision makers from all over the world to explore partnership ideas, business trends and investment opportunities in the global and Asian vaccine markets.

 

It is co-located with 2 conferences; Asia Antibody Congress 2013 and World Orphan Drug Congress Asia 2013, all of which serve to foster partnerships and collaboration amongst pharmas, biotechs, research institutes and governments. Furthermore, when you book for the Asia Antibody Congress 2013 conference, it will entitle you to a 30% discount off either of the 2 co-located conferences.

 

  •  Learn more about the event

  •  View the Asia Antibody Congress 2013 site

  •  View the World Orphan Drug Congress Asia 2013 site

 

Here are 10 reasons you should attend:

 

  1.       Get involved with key stakeholders – Bill & Melinda Gates Foundation, CDC, regulatory authorities and industry leaders, to realize sustainable and vaccine programs.

  2.       Get informed about recent developments and future plans for national health priorities and policies with public health leaders from DC of various key markets in Asia China, Vietnam and Thailand’s newly establishes National Vaccine Institute.

  3.       Recognise nuances of vaccine markets of Asia from industry veterans – BIKEN, PT. Bio Farma and more, for strategies to access developed and emerging vaccine markets in Asia.

  4.       Hear from representatives of global pharmas – Merck, Takeda, Novartis, GSK and more, on cross-regional partnerships, strategies and innovative approaches for vaccine development and market entry.

  5.       Learn what’s in the vaccine development pipeline for infectious diseases such as HIV, malaria, dengue, HFMD and more.

  6.       Explore prospects for therapeutic vaccine development with innovative bio-ventures in Asia like AnGes MG.

  7.       Identify opportunities for conducting clinical trials in Asia with case studies by Takeda, Jiangsu, China CDC and more.

  8.       Develop key local partnerships and presence to ensure long-term growth in public and private vaccine markets in Asia.

  9.       Meet leading Asian vaccine manufacturers – GPO-MBP, Serum Institute of India and more, who will share how their manufacturing capacities can contribute to a stable supply of affordable vaccines for the world.

  10.   Discover opportunities for collaborations with top research institutes in Asia – RIKEN, Research Institute for Microbial Diseases, Osaka University and more.

 

Our speakers include:

      ·         Nguyen Xuan Tung, Vice Chief of Vaccines Biologicals and Biosafety Department – General Department of Preventive Medicine, Ministry of Health, Vietnam

      ·         Charung Muengchana, Director, National Vaccine Instutite, Department of Disease Control, Ministry of Public Health, Thailand

      ·         Fengcai Zhu, Deputy Director, Jiangsu Provincial Center for Disease Prevention and Control, China

      ·         Klaus Stöhr, Vice President and Global Head, Influenza Franchises, Novartis Vaccines and Diagnostics, USA

      ·         Xuefeng Yu, Chairman and Chief Executive Officer, Tianjing Cansino Biotechnology, China

      ·         Alex Matter, Chief Executive Officer, Experimental Therapeutics Centre, A*STAR, Singapore

      ·         Shunsuke Sami, Executive Vice President, AnGes MG, Japan

      ·         Phil Kearney, Director, Licensing and External Research, MSD, Australia

 

View our full list of speakers

 

Come to the Asia Antibody Congress 2013 to learn:

1.       How to leverage on top vaccine development programs in Asia.

2.       How to formulate an effective business model to enter the Asian vaccine market.

3.       How to harness innovative vaccine design and adjuvant development currently in progress in Asia.

4.       How to overcome regulatory challenges to accelerate vaccine clinical trials.

5.       How to establish expansion strategies in contributing to the global vaccine market.

 

For more information on attending the conference, do not hesitate to contact Hui San Soh at +65 6322 2770 or email huisan.soh@terrapinn.com.  The earlier you book, the more you save!

 

We look forward to meeting with you soon!

 

Best Regards,

Jolene Lee

Marketing Manager

BioPharma Asia Convention 2013

DID: +65 6322 2318

Email: jolene.lee@terrapinn.com

 

Download the full brochure >
View agenda online >
Register to attend >